BridgeMD
New treatment option for Liver Transplant; Complications
Official title The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Transplantation
ClinicalTrials.gov ID: NCT06533592
What this study is testing
- What it's testing
- The main objective of the trial is to compare the effect of two end-to-end duct-to-duct anastomosis surgical techniques using the continuous suture method versus interrupted method (control group) on reducing the risk of bile leakages in the 90-day follow-up period after liver transplantation and other postoperative complications resulting from them i.e.: the occurrence of a critical stenosis in the duct-to-duct anastomosis within 90 days. In addition, as part of the research experiment, long-term biliary complications will be assessed, i.e.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- age over 18
- elective liver transplantation
- informed consent to participate in the study
- recipient bile duct diameter over 3mm
- donor bile duct diameter over 3mm
You likely can't join if
- age below 18
- pregnancy
- living donor liver transplantation
- split-liver or reduced-size liver transplantation
- liver transplantation other than from brain death donor
- liver transplantation with hepaticojejunostomy
See the full eligibility criteria
- age over 18
- elective liver transplantation
- informed consent to participate in the study
- recipient bile duct diameter over 3mm
- donor bile duct diameter over 3mm
- age below 18
- pregnancy
- living donor liver transplantation
- split-liver or reduced-size liver transplantation
- liver transplantation other than from brain death donor
- liver transplantation with hepaticojejunostomy
- patients undergoing re-transplantation
- multi-organ transplantation
- recipient bile duct diameter below 3mm
- donor bile duct diameter below 3mm
The study team makes the final eligibility decision.
Where it's taking place
- Warsaw, Masovian Voivodeship, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Warsaw, Masovian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.